Decitabine in Combination with Fludarabine and Cyclophosphamide As a Lymphodepletion Regimen Followed by CD19/CD22 Bispecific Targeted CAR T-cell Therapy Significantly Improves Survival in Relapsed/refractory B-ALL Patients
Blood(2021)
Key words
Decitabine,Chimeric antigen receptor T cell,Relapsed/refractory,Acute lymphoblastic leukemia,Lymphodepletion
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined